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Background: For elderly patients with rheumatoid arthritis, aggressive immunosuppression can be difficult to tolerate,
and surgery remains an important treatment option for joint pain and deformity. We sought to examine the epidemiology of
surgical reconstruction for rheumatoid arthritis among older individuals who were newly diagnosed with the disorder.
Methods: We identified a 5% random sample of Medicare beneficiaries (sixty-six years of age and older) newly diagnosed
with rheumatoid arthritis from 2000 to 2005, and followed these patients longitudinally for a mean of 4.6 years. We used
univariate analysis to compare the time from the diagnosis of rheumatoid arthritis to the first operation among the 360
patients who underwent surgery during the study period.
Results: In our study cohort, 589 procedures were performed among 360 patients, and 132 patients (37%) underwent
multiple procedures. The rate of upper extremity reconstruction was 0.9%, the rate of lower extremity reconstruction was
1.2%, and knee arthroplasty was themost common procedure performed initially (31%) and overall (29%). Upper extremity
procedures were performed sooner than lower extremity procedures (fourteen versus twenty-five months; p = 0.02). In
multivariable analysis, surgery rates declined with age for upper and lower extremity procedures (p < 0.001).
Conclusions: Knee replacement remains the most common initial procedure among patients with rheumatoid arthritis.
However, upper extremity procedures are performed earlier than lower extremity procedures. Understanding the patient
and provider factors that underlie variation in procedure rates can inform future strategies to improve the delivery of care to
patients with rheumatoid arthritis.
Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
T
he prevalence of rheumatoid arthritis has risen in recent
years, resulting in substantial increases in rheumatoid
arthritis-associated disability, cost, and mortality1-3.
Furthermore, rheumatoid arthritis is increasingly concentrated
among elderly individuals, and nearly 50% of patients who are
newly diagnosed with rheumatoid arthritis are sixty-five years
of age and older4. Although there is no cure for rheumatoid
arthritis, early treatment with disease-modifying antirheumatic
drugs (DMARDs) can slow disease progression and has rapidly
become the standard of care for patients with newly diagnosed
disease5.
Unlike young individuals, elderly patients with rheumatoid
arthritis are less likely to receive treatment with DMARDs6,7, are
more likely to suffer from multiple comorbid conditions re-
quiring additional medications, and may be more sensitive to
drug interactions and polypharmacy8-10. Additionally, complica-
tions from potent immunosuppressive medications may bemore
difficult for elderly individuals to tolerate; drug metabolism may
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be markedly different among older individuals11,12. Rheuma-
toid arthritis-related joint and soft-tissue reconstructive proce-
dures can predictably correct deformity, avoid flexion
contraction, alleviate pain, and improve function and quality
of life13,14. Furthermore, surgical reconstruction for the upper
extremity can often be performed on an outpatient basis
under regional anesthetic, minimizing the physiologic stress
of surgery. However, surgery is often considered only in the
late stage of rheumatoid arthritis for patients who have de-
veloped severe pain, joint destruction, or function loss with
failure to respond to pharmaceutical therapy13,15,16. Moreover,
the patient and provider factors that influence the timing of
surgery are not well understood.
Given the aging population in the United States, de-
fining the epidemiology of rheumatoid arthritis-related pro-
cedures among elderly patients can identify potential areas of
unmet need and systematic differences in treatment. In this
context, we examined the incidence of upper and lower ex-
tremity procedures performed for rheumatoid arthritis-
related deformities among a cohort of Medicare beneficiaries
in the United States. Our purpose was to define the timing and
rates of upper and lower limb reconstructive procedures
performed following the diagnosis of rheumatoid arthritis.
We hypothesized that overall rates of upper and lower limb
reconstruction decline with age and are significantly associ-
ated with sociodemographic factors and regional density of
specialists.
Materials and Methods
Data Sources and Creation of the Study Cohort
Weanalyzed a random 5% longitudinal sample of Medicare beneficiariesdiagnosed with rheumatoid arthritis between 2000 and 2005. To
identify new cases, we excluded patients with any rheumatoid arthritis-related
claims twelve months before their first diagnosis of rheumatoid arthritis after
2000, and this study cohort was followed until the end of 2010. We used
Medicare Inpatient, Outpatient, and Carrier claim files to identify rheumatoid
arthritis diagnoses and health-care utilization during the study period. These
files contain fee-for-service claims data submitted by the inpatient institution,
outpatient institution, and physicians. Diagnoses were coded using the In-
ternational Classification of Diseases, Ninth Revision (ICD-9) codes, and
surgical procedures were coded by ICD-9 procedure codes (Medicare Inpa-
tient files) or Current Procedural Terminology (CPT) codes (Medicare Out-
patient and Carrier files). We included only patients with greater than two
outpatient services with rheumatoid arthritis as the primary diagnosis (ICD-9
codes 714.0, 714.1, 714.2, 714.3, and 714.4), seven to 365 days apart between
2000 and 2005, to increase the reliability of the rheumatoid arthritis diagnosis.
Patients entered the study cohort on the date of first rheumatoid arthritis
diagnosis if they were without any rheumatoid arthritis-related claims in the
prior twelve months, and stayed in the cohort until death or disenrollment
from Medicare.
We used the Medicare Beneficiary Summary file to capture demo-
graphic and enrollment information of patients. Our cohort only included
patients with rheumatoid arthritis who were sixty-six years or older on entry
into the study and were continuously enrolled in Medicare Parts A and B for at
least twelve months before the first diagnosis of rheumatoid arthritis during the
study period. Patients younger than sixty-six years enrolled in Medicare for
other indications were specifically excluded.We excluded all of the patients who
were Health Maintenance Organization (Part C) enrollees at any time during
the study period because of the lack of their Part-B data in the Centers for
Medicare & Medicaid Services (CMS).
Measures
Outcome Variables
We followed patients until December 31, 2010, to determine the rate of
rheumatoid arthritis-related reconstructive surgery of the upper and lower
extremities. The time from diagnosis to surgery was measured for each patient
in years. We calculated the rate of surgery as the probability of undergoing
surgery within the study period. The ICD-9 procedure codes and CPT codes
used to identify each procedure are listed in a table in the Appendix. Upper
extremity procedures included arthroplasty of the shoulder, elbow, wrist, and
hand; arthrodesis of the hand and wrist; synovectomy of the shoulder, elbow,
TABLE I Characteristics of Medicare Beneficiaries Diagnosed
with Rheumatoid Arthritis in 2000 to 2005
Characteristic
No. of Patients
(N = 18,037)
Age (yr)
66-69 3468 (19%)
70-74 4544 (25%)
75-79 4449 (25%)
‡80 5576 (31%)
Sex
Male 4390 (24%)
Female 13,647 (76%)
Race
White 15,327 (85%)
Black 1655 (9%)
Other 1055 (6%)
Socioeconomic status
Low 4643 (26%)
Middle 4914 (27%)
High 8480 (47%)
Elixhauser comorbidity score quartile
1 (<5) 5030 (28%)
2 (5-12) 5436 (30%)
3 (13-21) 4142 (23%)
4 (>21) 3429 (19%)
Location of residence
Metropolitan area 14,650 (81%)
Nonmetropolitan area 3387 (19%)
State assistance for Medicare premium
No 16,233 (90%)
Yes 1804 (10%)
Density of rheumatologists where patient
resided (per 1 million population)
<10 6891 (38%)
10-15 7975 (44%)
>15 3171 (18%)
Density of orthopaedic surgeons where
patient resided (per 1 million population)
<58 5495 (30%)
58-68 5861 (32%)
>68 6681 (37%)
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wrist, and hand; and tendon repair, transfer, and tenolysis for the hand and
fingers. Lower extremity procedures included arthroplasty of the hip and knee
and arthrodesis, arthroplasty, and synovectomy of the ankle and foot. To
identify joint and soft-tissue reconstructive surgical procedures performed for
the management of rheumatoid arthritis, we only used claims with CPT codes
for these procedures coded under a principal diagnosis of rheumatoid arthritis
in the claims, indicating that the procedure performed was related to rheu-
matoid arthritis.
Patient and Provider Characteristics
We obtained baseline patient characteristics for each study subject. Age was
categorized in the following groups: sixty-six to sixty-nine, seventy to seventy-
four, seventy-five to seventy-nine, and eighty years and older. Race was defined
as white, black, and other. Socioeconomic status was estimated from the resi-
dence zip code of the beneficiaries and the income, education, and occupation
summary of the U.S. zip codes from the 2000 U.S. Census
17
. We calculated the
score for comorbidities on the basis of the Elixhauser comorbidity index as an
indicator of overall health condition
18,19
.
To examine regional differences, we included the density of rheuma-
tologists and of orthopaedic surgeons. To do this, we obtained the hospital
referral region where each subject resided by linking their residence zip code to
theDartmouth Atlas of Health Care hospital referral region level data
20
. We then
linked hospital referral region identifiers to the Dartmouth Atlas physician
capacity data for the density of specialists (rheumatologists and orthopaedic
surgeons) in the region of each subject’s residence (the number of specialists per
one million residents in the region). Finally, we included residence location,
categorized as metropolitan areas versus nonmetropolitan or rural areas, into
the analysis to help control for potential differences in rheumatoid arthritis care
introduced by geographic variation. We did this by linking the residence zip
code of each study subject to the Federal Information Processing Standards
codes in the 2013 U.S. Department of Agriculture Rural-Urban Continuum
Codes for Metro and Nonmetro counties
21
.
Statistical Analysis
We performed univariate analysis of the data on patients undergoing rheu-
matoid arthritis-related surgery to assess the effect of patient and regional
factors on the timing of surgery. We used the median time interval from di-
agnosis to surgery by patient characteristics rather than the mean time interval
because of the outliers in each patient group. We specifically used the Kruskal-
Wallis test, which is a nonparametric test that does not assume normal dis-
tribution and can be used in the comparison of medians
22
.
To examine the factors that influence the probability of undergoing
rheumatoid arthritis-related surgery among patients newly diagnosed with
rheumatoid arthritis, we used survival analysis to determine receipt of initial
surgery and the time to event. Patients who did not have any operation for
rheumatoid arthritis were censored. We performed multivariable analyses ex-
amining the risk of receiving rheumatoid arthritis-related upper extremity
surgery and lower extremity surgery, using a Cox proportional-hazards model
with patient sociodemographics, comorbidity score, and density of rheuma-
tologists and orthopaedic surgeons in the residence area as covariates to control
for these factors simultaneously. Significance was set at an alpha level of 0.05.
Source of Funding
This research was supported in part by a grant from the National Institute of
Arthritis and Musculoskeletal and Skin Diseases (R01 AR047328) and a 2013
Clinical Research Grant funded by the American Foundation for Surgery of the
Hand to Dr. Waljee.
Results
We identified 18,037 patients who were newly diagnosedwith rheumatoid arthritis between 2000 and 2005 (Table I).
Patients were followed for a total of 82,767 person-years, with a
mean follow-up time (and standard deviation) of 4.6 ± 2.6 years
per patient. In our study cohort, age was approximately evenly
TABLE II Number of Upper and Lower Extremity Procedures Performed During the First Operation for Rheumatoid Arthritis After
Diagnosis and During the Study Period
Procedure*
Initial Procedures Performed
Following Diagnosis, (N = 452)
Total No. of Procedures During
the Study Period (N = 589)
Hand
Tendon reconstruction and/or muscle release 38 (8%) 50 (8%)
Synovectomy 37 (8%) 42 (7%)
MCP, IP, or CMC arthroplasty 44 (10%) 65 (11%)
MCP, IP, or CMC arthrodesis 21 (5%) 32 (5%)
Wrist
Synovectomy, arthrodesis, or arthroplasty 34 (8%) 46 (8%)
Elbow
Arthroplasty or synovectomy 18 (4%) 23 (4%)
Shoulder
Arthroplasty or synovectomy 25 (6%) 37 (6%)
Knee
Arthroplasty 138 (31%) 171 (29%)
Hip
Arthroplasty 70 (15%) 90 (15%)
Ankle and foot
Arthrodesis, arthroplasty, or synovectomy 27 (6%) 33 (6%)
*MCP = metacarpophalangeal, IP = interphalangeal, and CMC = carpometacarpal.
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distributed among each category. The majority of the subjects
were female (76%) and white (85%). Comorbid conditions were
categorized using the Elixhauser method to account for the
number and severity of illnesses, which were then divided into
even quartiles. Regionally, 81% of the patients resided in met-
ropolitan areas.
We captured 295 rheumatoid arthritis-related upper ex-
tremity surgeries (158 patients) and 294 lower extremity sur-
geries (215 patients). In our cohort, 589 procedures were
performed in 360 patients, and 132 patients (37%) underwent
multiple procedures. Thirteen patients had both upper extremity
and lower extremity procedures. The average rates of upper and
lower extremity surgery performed after a diagnosis of rheu-
matoid arthritis were thirty-four and thirty-six procedures per
10,000 patients per year, respectively (Table II). Among those
procedures, 77% were performed during the initial rheumatoid
arthritis-related operation and 23% were performed after the
initial operation during the follow-up. Themost common initial
procedure performed was total or partial knee replacement
(31%), followed by hip replacement (15%), hand arthroplasty
(10%), and tendon reconstruction and/or muscle release in the
hand (8%). Among hand procedures, the most commonly
performed was metacarpophalangeal arthroplasty (16%), fol-
lowed by metacarpophalangeal joint synovectomy (13%) and
TABLE III Univariate Analysis of the Median Time Interval from the Diagnosis of Rheumatoid Arthritis to the First Extremity Surgery for
Rheumatoid Arthritis Management
Upper Extremity Surgery Lower Extremity Surgery
Patient and Provider Characteristics
No. of
Patients
Median
Time (mo) P Value
No. of
Patients
Median
Time (mo) P Value
Total 158 14 — 215 25 0.02
Age (yr) <0.001 <0.001
66-69 56 31 73 37
70-74 39 24 74 26
75-79 44 11 45 17
‡80 19 1 23 13
Sex 0.95 0.79
Male 30 9 43 23
Female 128 14 172 25
Socioeconomic status 0.24 0.17
Low 38 29 47 13
Middle 35 12 64 30
High 74 11 97 24
Missing data 11 — 7 —
Elixhauser comorbidity score quartile 0.04 0.01
1 (<5) 62 24 77 29
2 (5-12) 45 12 69 26
3 (13-21) 35 11 43 23
4 (>21) 16 2 26 8
Location of residence 0.87 0.42
Metropolitan area 114 18 152 26
Nonmetropolitan area 44 10 63 21
State assistance for Medicare premium 0.01 0.46
No 146 20 199 25
Yes 12 2 16 18
Density of rheumatologists (per million residents) 0.96 0.49
<10 78 14 105 28
10-15 63 11 79 21
>15 17 23 31 23
Density of orthopaedic surgeons (per million residents) 0.81 0.73
<58 41 15 54 21
58-68 42 18 89 25
>68 75 10 72 27
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arthrodesis of the interphalangeal joint (11%). Repair or transfer
of flexor or extensor tendons comprised 15% of all hand pro-
cedures. Overall, the rate of upper extremity reconstruction was
0.9% and the rate of lower extremity reconstruction was 1.2%.
In our cohort, upper extremity procedures were per-
formed sooner than lower extremity procedures (fourteen
versus twenty-five months; p = 0.02). Among the patients who
had at least one procedure for rheumatoid arthritis, older pa-
tients underwent surgery sooner than younger patients. For
example, themedian time between the diagnosis of rheumatoid
arthritis and having upper extremity surgery was thirty-one
months for sixty-six to sixty-nine-year-old patients and only
one month for patients who were eighty years of age or older
(p < 0.001). A greater number of comorbidities was associated
with earlier upper (p = 0.04) and lower extremity surgery (p =
0.01). Finally, patients who received state assistance for their
Medicare premium underwent the first upper extremity sur-
gery earlier than did patients who did not require assistance
(two months versus twenty months; p = 0.01) (Table III).
The multivariable analysis of factors that influenced the
probability of receiving rheumatoid arthritis-related surgery
during the study period is given in a table in the Appendix.
Patients who were eighty years of age or older were less likely to
undergo upper extremity surgery (hazard ratio [HR], 0.28;
95% confidence interval [CI]: 0.16 to 0.49) than were patients
who were sixty-six to sixty-nine years old. Black patients were
less likely to receive upper extremity surgery than were white
patients (HR, 0.24; 95% CI: 0.07 to 0.76). Regional factors were
also associated with the timing and probability of surgery.
Patients who resided in regions with the greatest density of
rheumatologists were less likely to undergo upper extremity
surgery than were patients who lived in regions with the fewest
rheumatologists (HR, 0.51; 95%CI: 0.29 to 0.89). Conversely, a
higher density of orthopaedic surgeons was associated with a
higher probability of receiving surgery after diagnosis (HR,
1.62; 95% CI: 1.07 to 2.47). For lower extremity surgery, pa-
tients at least eighty years of age had a lower probability of
surgery (HR, 0.25; 95%CI: 0.16 to 0.41). Furthermore, patients
who lived in a nonmetropolitan area had a lower rate of surgery
per unit of time compared with metropolitan residents (HR,
0.67; 95% CI: 0.48 to 0.94). Finally, patients who received as-
sistance from the state for the monthly Medicare premium had
a higher probability of undergoing lower extremity surgery
after the diagnosis of rheumatoid arthritis than patients who
did not receive assistance (HR, 1.88, 95% CI: 1.09 to 3.23).
Discussion
In this study of Medicare beneficiaries newly diagnosed withrheumatoid arthritis, approximately 2% of the individuals
underwent upper and/or lower extremity reconstruction. The
majority of patients underwent surgery within three years
following diagnosis, and the most common initial rheumatoid
arthritis-related reconstructive surgery was knee arthroplasty
(31%). Rates of surgery declined with advancing age, even after
controlling for comorbid conditions and sociodemographic
factors. Upper extremity procedures were performed sooner
than lower extremity procedures and were influenced by the
regional density of specialists.
In our cohort, rates of surgery were low, consistent with
prior studies that have demonstrated the declining rate of
surgical intervention for rheumatoid arthritis-related joint
deformities23-28. Although advances in medical treatment could
explain these phenomena, this may not be true for older in-
dividuals. In our study, older individuals remained less likely to
receive surgery, and elderly individuals are less likely than
younger individuals to have access to outpatient clinic care for
rheumatologic complaints24,29,30. Additionally, we found that
the patients eighty years of age or older who did undergo
surgery had the surgery much sooner after diagnosis than did
younger patients. This trend may suggest that patients who are
diagnosed later in life may either have a delay in diagnosis or
have a more aggressive course31-33. It is possible that elderly
individuals may rely on hand function, strength, and dexterity
to maintain independence with activities of daily living and
self-care. They may be more sensitive to declines in range of
motion or pain than are younger individuals and may seek
surgical intervention earlier to preserve mobility and func-
tion34,35. Therefore, early diagnosis of rheumatoid arthritis may
improve patient outcomes because of the early initiation of
medication and rehabilitation therapy.
Our study has several notable limitations. First, our
findings were drawn from Medicare claims, which may be
subject to coding errors inherent in administrative data. For
example, it is not feasible to apply clinical guidelines, such as the
American College of Rheumatology criteria, to identify newly
diagnosed cases in Medicare claims data because of the lack
of available clinical outcomes, laboratory findings, and self-
reported symptommeasures. However, a recent study comparing
the reliability of diagnosis identification between office records
and Medicare claims revealed a 90% correlation between these
two data sources36. Medicare data have been widely used to ex-
amine treatment patterns, and they provide robust data owing to
large, population-based samples. Compared with clinical trials
or observational registries that are biased toward tertiary care
centers, CMS claims data reflect real-world clinical practice36-38.
Another limitation of our study is that, as a result of using
Medicare claims data for outpatient services, we were unable to
capture medication use during the study period, which may
influence surgical rates. Ample evidence shows that the use of
DMARDs, especially a combination of DMARDs, is effective in
retarding disease progression, including joint destruction39-42.
However, given the period from which our study cohort was
drawn, we were unable to adequately determine the use of
DMARDs among older patients with rheumatoid arthritis be-
cause of variation in prescriptionmedication coverage. Although
we adjusted for provider density, future studies examining the
effect of medication regimens on surgical rates are warranted.
Additionally, we do not have information regarding disease se-
verity or the indications for specific surgical procedures. Al-
though administrative data lack this granularity, future studies
that incorporate patient-reported outcome and detailed clinical
data may provide insight into the nuances of surgical rates
407
THE JOURNAL OF BONE & JOINT SURGERY d J B J S .ORG
VOLUME 97-A d NUMBER 5 d MARCH 4, 2015
THE INCIDENCE OF UPPER AND LOWER EXTREMITY SURGERY FOR
RHEUMATOID ARTHRIT I S
among elderly individuals with rheumatoid arthritis. Further-
more, the Dartmouth Atlas of Health Care data currently do not
contain the density of hand surgeons in each hospital referral
region as a physician capacity measure. Thus, we did not include
this variable in the analysis as one of the predictors of rheu-
matoid arthritis-related upper extremity surgery.
Nonetheless, our study provides a new perspective on the
epidemiology of surgical reconstruction for extremity disability
among elderly patients with rheumatoid arthritis. DMARD use
among elderly individuals is less aggressive and initiated later
than for younger patients with rheumatoid arthritis6-10, and el-
derly patients may have progression to debilitating joint pain and
deformity more quickly than younger individuals43-48. Elderly
patients could be considered earlier for surgical therapy in order
to preserve extremity function and mobility. Surgery among the
elderly is well tolerated and could potentially improve overall
quality of life and the ability to complete activities of daily living
and maintain independence49,50. Additionally, patients with
profound deformities report a benefit from surgery, even with
relatively modest gains in arc of motion or ulnar drift14,51. Fur-
thermore, although DMARDs are associated with an increased
risk of complications with lower extremity procedures, this may
not be true for upper extremity procedures52-54. The most
common complications after rheumatoid arthritis-related sur-
gical treatments include surgical site infection and venous
thromboembolism54-57. Other complications, such as implant
dislocation, instability, and failure, occur frequently in both large
and small joints and often require revision58-62. However, prior
research on complications after rheumatoid arthritis-related
hand procedures is limited compared with studies regarding the
complications after lower extremity surgical procedures. Finally,
unlike lower extremity reconstructive procedures, upper ex-
tremity procedures are often performed on an outpatient basis,
with relatively few readmissions and low mortality rates.
It has been suggested that the reconstructive sequence for
rheumatoid arthritis-related joint destruction should address
proximal joints prior to distal joints and lower extremity joints
prior to upper extremity joints. In our cohort, knee and hip
arthroplasties were among the most common initial procedures
and comprised 46% of all initial procedures. Notably, over half of
patients undergo upper extremity reconstruction initially for
rheumatoid arthritis-related deformity63. Although the indica-
tions for surgery are not clear from administrative data, for
elderly individuals, maintaining pain-free hand function and
dexterity may be critical to activities of daily living and main-
taining independence. For many patients with rheumatoid
arthritis, rheumatologists provide the majority of care and direct
the referral patterns for all aspects of their care. Therefore, dif-
ferences in attitudes regarding the effectiveness of surgical
treatment between rheumatologists and orthopaedic surgeons
may explain differences in rheumatoid arthritis-related upper
extremity surgery among regions with differing densities of
subspecialist care13. Alternatively, lower rates of surgery could
also be due to increased access to DMARDs to slow the progress
of disease. Finally, it is possible that health behaviors regarding
compliance and prevention differ geographically64-67. To better
control for these potential differences, we included data on
metropolitan and nonmetropolitan or rural residence in our
measures.
Rates of extremity surgery for rheumatoid arthritis are
low among elderly individuals, and this surgery is more com-
monly performed in the early years following diagnosis. Future
studies comparing the relative effectiveness of medical and
surgical therapy on the preservation of function among elderly
patients with rheumatoid arthritis can inform the management
of this common and challenging disease.
Appendix
Tables showing the adjusted hazard ratio of undergoing
upper and lower extremity rheumatoid arthritis-related
surgery after the diagnosis of rheumatoid arthritis and the
procedure codes for upper and lower extremity surgical pro-
cedures for rheumatoid arthritis are available with the online
version of this article as a data supplement at jbjs.org. n
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